12th World Congress Program - 6 June, 2015 Innovations Preconference

With the theme "The Challenge of Reimbursement: Can We Do This Smarter?", the "Innovations in Neuromodulation" preconference offers an audience of some 200 investors, entrepreneurs, device company executives, and medical professionals a day to network and hear presentations by entrepreneurs, representatives of early–stage companies, and venture capitalists.

Saturday 6 June (Preconference) | Sunday 7 June (Preconference) | Congress Program 8-11 June | Congress page | Congress News Center

SATURDAY 6 JUNE Innovations in Neuromodulation: Jolliet-Duluth-Mackenzie Room

7:00-7:45 Breakfast  
7:45-7:55 Welcome and Opening Remarks Drs. Simon Thomson, Elliot Krames and the Canadian Neuromodulation Society
7:55-8:15 Introduction and Neuromodulation Market Overview  Rami Elghandour, MBA
8:15-8:45 Innovation Phase  Mir Imran, MS
8:45-9:35 Emerging Company Panel  
  CorTec  Dr. Martin Schüttler, Chief Technology Officer, CorTec 
  FemPulse LLC Alexandra Haessler, MD, Founder and President, FemPulse LLC
  Lungpacer Medical Inc. Dr. Andy Hoffer, President and CSO, Lungpacer Medical Inc.
9:35-10:05 How to Procure Financing  Brad Vale, PhD, DVM, former Head of Johnson & Johnson Development Corporation (JJDC)
10:05-10:35 Networking Break  
10:35-11:25 Emerging Company Panel   
  BlueWind Medical Roy Katz, Vice President Business Development, BlueWind Medical
  MicroTransponder Frank McEachern, Chief Executive Officer, MicroTransponder
  Neuronano AB Jens Schouenborg, Principal Inventor, Member of the Board, Neuronano AB
11:25-11:55 TBA  
11:55-13:15 Lunch & Lecture: Supporting Innovation and Guiding Early Commercialisation Vaishali Kamat, Head of Digital Health, Cambridge Consultants
13:15-13:45 Neuromodulation study design:  Science, regulation, and reimbursement  Richard North, MD, Professor of Neurosurgery, Anesthesiology and Critical Care Medicine (ret.) Johns Hopkins University School of Medicine
13:45-14:25 Emerging Company Panel  
  Neuros Medical, Inc. Jon J. Snyder, President and Chief Executive Officer, Neuros Medical, Inc.
  SPR Therapeutics Mark Stultz, Senior Vice President Market Development, SPR Therapeutics
14:25-14:55 Reimbursement Phase  TBA
  Venture Capital Panel Kadir Kadhiresan, VP Venture Investments MD & D, JJDC Investors; J&J Innovation
Tony Borowicz, Vice President of Business Development, Greatbatch
16:05-16:35 Networking Break  
16:35-17:05 The Big Picture  J.P. Errico, PhD, Chairman, Founder, Principal Investor and Chief Executive Officer of electroCore
17:05-17:55 Emerging Company Panel   
  Medtronic Eindhoven Design Center, formerly Sapiens Steering Brain Stimulation B.V Michel M.J. Decré, PhD, Research and Technology Director, Sapiens co-founder and CTO
  WISE Srl Luca Ravagnan, PhD, Chief Executive Officer, WISE Srl
  Axonics Modulation Technologies, Inc. Raymond W. Cohen, Chief Executive Officer, Axonics Modulation 
17:55-18:05 Closing Comments  

Last Updated on Monday, November 22, 2021 02:16 PM